Home > Insider Trading > Filing (0001209191-19-049172)

Filing Details

Accession Number:: 0001209191-19-049172
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-11 16:30:49
Reporting Period:: 2019-09-10

Accepted Time:: 2019-09-11 16:30:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1299430	D Christopher Alafi	C/O Alafi Capital Company, Llc 8 Admiral Drive, Suite 324 Emeryville CA 94608		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-10	3,549	$8.98	4,191,819	No	4	P	Indirect	Held by Alafi Capital Company, LLC
Common Stock	Acquisiton	2019-09-10	155,116	$9.59	4,346,935	No	4	P	Indirect	Held by Alafi Capital Company, LLC
Common Stock	Acquisiton	2019-09-10	320,095	$10.58	4,667,030	No	4	P	Indirect	Held by Alafi Capital Company, LLC
Common Stock	Acquisiton	2019-09-10	6,240	$11.00	4,673,270	No	4	P	Indirect	Held by Alafi Capital Company, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by Alafi Capital Company, LLC
No	4	P	Indirect	Held by Alafi Capital Company, LLC
No	4	P	Indirect	Held by Alafi Capital Company, LLC
No	4	P	Indirect	Held by Alafi Capital Company, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	341,223	Direct
Common Stock	503,753	Indirect	Held as Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust
Common Stock	170,000	Indirect	Held by Christopher D Alafi Family Trust

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.97 to $8.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $9.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
Shireen Michele Alafi is the Trustee of the Christopher D Alafi Family Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.